Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorambucil in BRCA/DDR Mutated Metastatic Pancreatic Cancer
NCT04692740Phase 2Unknown
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorambucil in pancreatic ductal adenocarcinoma (PDAC). Status: unknown.
02
Drugs
chlorambucil
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04692740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04692740.